II 4 : Inhibiteurs de la pompe à protons = Proton pump inhibitorRINALDI, Y.Acta endoscopica. 1991, Vol 21, Num 1, pp 109-111, issn 0240-642X, SUPArticle

Omeprazole: short- and long-term safetyYEOMANS, N. D.Adverse drug reactions and toxicological reviews. 1994, Vol 13, Num 3, pp 145-156, issn 0964-198XArticle

Phytobézoard gastrique favorisé par la pharmacopée traditionnelle africaine et les antisécrétoires : un casSEHONOU, J; ADDRA, B; HOUESSINON, L et al.Acta endoscopica. Supplément. 2005, Vol 35, Num 3, pp 489-491, issn 1242-1383, 3 p., NSConference Paper

Les antisécrétoires gastriques : Thérapeutique pratique = Gastric secretion inhibitorsAMOURETTI, Michel.Concours médical (Paris). 2004, Vol 126, Num 11-12, pp 653-656, issn 0010-5309, 4 p.Article

Effets indésirables de l'oméprazole : un bilan = Adverse effects of omeprazoleLa Revue Prescrire. 1997, Vol 17, Num 169, pp 38-39, issn 0247-7750Article

IV 3 : Traitement médical de l'œsophagite peptique = Medical treatment of peptic esophagitisVANDROMME, L.Acta endoscopica. 1991, Vol 21, Num 1, pp 151-152, issn 0240-642X, SUPArticle

Comparative tolerability profile of omeprazole in clinical trialsSIMON, T. J; BRADSTREET, D. C.Digestive diseases and sciences. 1991, Vol 36, Num 10, pp 1384-1389, issn 0163-2116Article

Pentagastrin-stimulated gastric acid secretion and pharmacokinetics following single and repeated intravenous administration of the gastric H⁺, K⁺ -ATPase-inhibitor pantoprazole (BY1023/SK&F96022) in healthy volunteersMUÊLLER, S. B; HARTMANN, M; BLIESATH, H et al.Zeitschrift für Gastroenterologie. 1990, Vol 28, Num 9, pp 443-447, issn 0044-2771, 5 p.Article

RacecadotrilNAGPAL, Jitender; GOGIA, Sidhartha.Indian pediatrics. 2004, Vol 41, Num 12, pp 1218-1224, issn 0019-6061, 7 p.Article

Somac : Generic name : PantoprazoleMALLARKEY, G.Current therapeutics. 1996, Vol 37, Num 3, pp 74-76, issn 0311-905XArticle

Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsiesDICKEY, W; KENNY, B. D; MCCONNELL, J. B et al.Alimentary pharmacology & therapeutics. 1996, Vol 10, Num 3, pp 289-294, issn 0269-2813, 5 p.Article

Omeprazole administration does not impair gastrointestinal mucosal perfusion, oxygenation, and hexosamine generationIWAO, T; TOYONAGA, A; SHIGEMORI, H et al.Gastrointestinal endoscopy. 1995, Vol 41, Num 5, pp 497-501, issn 0016-5107Article

Acid pump blockers: what are their current therapeutic roles?ARENS, M. J; DENT, J.Baillière's clinical gastroenterology. 1993, Vol 7, Num 1, pp 95-128, issn 0950-3528Article

Criteria for use of omeprazole in adult inpatients and outpatientsClinical pharmacy. 1992, Vol 11, Num 2, pp 177-179, issn 0278-2677Article

Untoward reactions to gastric antisecretory drugsBERTACCINI, G; CORUZZI, G.The Italian journal of gastroenterology. 1992, Vol 24, Num 8, pp 470-471, issn 0392-0623Article

Réduction de l'acidité gastrique : conséquences sur la cancérogenèse gastrique induite par les N-nitrosocomposés = Effect of reduced acid-secretory activity on N-nitroso compunds-induced gastric carcinogenesisMARTIN, F; MARTIN, M.Gastroentérologie clinique et biologique. 1991, Vol 15, Num 5BIS, pp 102C-105C, issn 0399-8320Conference Paper

A comparison of two regimens of misoprostol for second trimester medical termination of pregnancy: a randomized trialCHAUDHURI, Snehamay; PRADIP KUMAR BANERJEE; MUNDLE, Malay et al.Tropical doctor. 2010, Vol 40, Num 3, pp 144-148, issn 0049-4755, 5 p.Article

Systematic review: impaired drug absorption related to the co-administration of antisecretory therapyLAHNER, E; DELLE FAVE, B. Annibale G.Alimentary pharmacology & therapeutics. 2009, Vol 29, Num 12, pp 1219-1239, issn 0269-2813, 21 p.Article

Les antisécrétoires gastriques chez l'adulteLa Lettre de l'hépato-gastroentérologue. 2007, Vol 10, Num 9, pp 229-236, issn 1286-580X, 8 p.Article

Actualités en matière de gastroprotection = Gastroprotective agentsDUPAS, J. L.La Lettre du rhumatologue. 2002, pp 10-12, issn 0761-5027, HSConference Paper

The effect of intravenous omeprazole on the gastric and duodenal potential difference and pH in healthy subjectsRUBINSTEIN, E; HØJGAARD, L.Digestion. 1993, Vol 54, Num 1, pp 15-18, issn 0012-2823Article

Antisécrétoires gastriques et coprescriptionsCHEVREL, B.Médecine et chirurgie digestives (Paris). 1993, Vol 22, Num 3, pp 203-209, issn 0047-6412Article

A drug usage review of omeprazoleNORRIS, C. M; MCMANUS, P. V; PETTY, D et al.Journal of clinical pharmacy and therapeutics (Print). 1992, Vol 17, Num 6, pp 369-372, issn 0269-4727Article

L'oméprazole nouvelle approche thérapeutique de l'hyperacidité gastrique = Omeprazole new therapeutic approach of gastric hyperacidityCHEVREL, B.Médecine et chirurgie digestives (Paris). 1992, Vol 21, Num 6, pp 339-345, issn 0047-6412Article

Effects du lansoprazole sur la fonction du sphincter inférieur de l'œsophage et la motricité œsophagienne chez l'homme = Effects of lansoprazole on human lower oesophageal sphincter function and oesophageal motricityPETITE, J. P; LOISON, P; AUBERT, A et al.Médecine et chirurgie digestives (Paris). 1991, Vol 20, Num 1, pp 58-60, issn 0047-6412, 3 p.Article